Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer (Q50872823)
Jump to navigation
Jump to search
scientific article published on 17 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer |
scientific article published on 17 January 2017 |
Statements
Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer (English)
1 reference
Nobuyuki Katakami
1 reference
Toyoaki Hida
1 reference
Hiroshi Nokihara
1 reference
Fumio Imamura
1 reference
Hiroshi Sakai
1 reference
Shinji Atagi
1 reference
Makoto Nishio
1 reference
Tatsuhiko Kashii
1 reference
Miyako Satouchi
1 reference
Christoph Helwig
1 reference
Morihiro Watanabe
1 reference
Tomohide Tamura
1 reference
17 January 2017
1 reference
105
1 reference
23-30
1 reference